We’re excited to share our new paper in the prestigious IJROBP (aka the Red Journal), first-authored by Dr. Victor V. Onecha, where we’ve taken a big step toward making targeted α-particle therapies safer and more precise. We did this work in collaboration with Drs. Daniel Pryma and Sarah Gitto at the University of Pennsylvania. Here’s…
Our postdoctoral fellow Dr. Victor V. Onecha delivered an outstanding talk last Friday at the 63rd Annual Conference of the Particle Therapy Co-Operative Group (PTCOG), held this year in Buenos Aires, Argentina. Victor presented recent work from our lab on DNA damage modeling as a biologically-grounded quantity for treatment planning across particle therapy modalities. His…
We are pleased to announce two new collaborative publications from our team: Dr. Bertolet collaborated with Dr. Ibrahim Chamseddine and Dr. Charles Maitz from the University of Missouri on a recent publication in Veterinary and Comparative Oncology. This paper investigates preclinical studies in dogs, emphasizing how the distribution of iodine-131 influences therapeutic outcomes.Access the paper…
As we close out 2024, we reflect on the remarkable growth of the Bertolet Lab during its second year. Formally established in the summer of 2023, our lab has thrived through a year of achievements and hard-fought progress. Beyond the accomplishments listed below, we have had the privilege of working with remarkable individuals whose energy,…
We are thrilled to share the exciting news that our postdoctoral fellow, Dr. Carlos Huesa-Berral, has been honored by his birth city, Malaga (Spain), as part of the prestigious awards granted by COPE Radio. Carlos was recognized as the Malaga citizen with the most significant international trajectory for his outstanding contributions to Radiation Oncology research…
We are thrilled to announce that Dr. Carlos Huesa-Berral has been awarded a postdoctoral fellowship from the American Cancer Society. for his project entitled “Computational Modeling and Simulation of Hepatic Tumors for Enhanced Transarterial Radioembolization”. Carlos will start this 3-year-long project on January 1st, 2025. This fellowship is highly competitive, with only a small percentage…
The reverse Monte Carlo SPECT reconstruction project is an NIH R21-funded project within the Informatics Technologies for Cancer Research (ITCR) program and expands our mission to explore the uses of radiation for cancer care. With Dr. Valladolid-Onecha’s contribution, we look forward to new breakthroughs and advancements in this field. Please join us in welcoming Dr….
Our lab has received three Travel Awards to attend the 2023 International Congress for Radiation Research to be held in Montreal on August 27-30. Alejandro Bertolet has received one in the category of Early Career Investigator (ECI), whereas Carlos Huesa-Berral and Louis Kunz have received two trainee awards for their top-scored abstracts on the MIDOS…
We are thrilled to announce that we held our first meeting yesterday with the University of Pennsylvania, marking the commencement of an inspiring collaboration. Our teams are eager to dedicate their expertise towards a crucial R01 project: “Optimizing theranostic radiopharmaceutical therapy to combat resistance to PARP inhibition in advanced ovarian cancer.” This collaboration is a…
Our postdoctoral fellow, Carlos Huesa Berral, has been awarded with the ‘Best-In-Physics’ distinction at the American Association of Physicists in Medicine (AAPM) annual conference, which will take place in Houston, TX, next July. This meeting is one of the biggest and most important in Medical Physics in the world, and Carlos’ outstanding work on MIDOS,…
